Evaluating the Ability of Zoledronic Acid to Reduce the Rate of Subsequent Osteoporotic Fractures After a Hip Fracture
Clinical trial NCT00046254 · COMPLETED
Trial details
- NCT number
- NCT00046254
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-02-01
- Primary completion
- 2007-02-01
- Enrollment
- 2127
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.